| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/31/2005 | CA2551037A1 Novel piperidine derivative |
| 03/31/2005 | CA2539165A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | CA2539162A1 Cinnamoyl derivatives and use thereof |
| 03/31/2005 | CA2538960A1 Cinnamoyl compound and use of the same |
| 03/30/2005 | EP1517989A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 03/30/2005 | EP1517914A2 9-alpha-substituted estratrienes as selectively active estrogen |
| 03/30/2005 | EP1517907A2 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/30/2005 | EP1517905A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 03/30/2005 | EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 03/30/2005 | EP1517896A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 03/30/2005 | EP1517679A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 03/30/2005 | EP1390025B1 Use of coenzyme q (ubiquinone) and eicosapentaenoic acid (epa) for the treatment of non-hodgkin's lymphoma and psychiatric or neurological disorders |
| 03/30/2005 | EP1224163B1 Use of carbonylamino derivatives against cns disorders |
| 03/30/2005 | EP1194429B1 Potassium channel openers |
| 03/30/2005 | EP1091942B1 Potassium channel blocking agents |
| 03/30/2005 | EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders |
| 03/30/2005 | CN1602311A Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 03/30/2005 | CN1602307A Substituted 6h-dibenzo[c, h]chromenes as estrogenic agents |
| 03/30/2005 | CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution |
| 03/30/2005 | CN1600360A Soft capsule of decoction of four ingredients possessing effect of enriching blood and regulating menstruation and preparation method |
| 03/30/2005 | CN1600313A Cefetamet pivoxil hydrochloride dispersion dispersion tablets and preparation method |
| 03/30/2005 | CN1600302A Combination of medicine containing ferric citrate, medicine level ferric citrate, preparation method, and diet nutrition containing ferric citrate in medicine level |
| 03/30/2005 | CN1194956C Treating medicine for kidney hypofuction |
| 03/30/2005 | CN1194719C Medicine prescription for curing nephropathy and prepn, process |
| 03/30/2005 | CN1194709C Kidney invigorating and bone strengthening medicine and its preparing method |
| 03/30/2005 | CN1194702C Herba-Epimedii extract for treating prostatic hyerplasia and use in preparing medicine |
| 03/29/2005 | US6872746 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/29/2005 | US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/29/2005 | US6872733 Benzimidazolone compounds |
| 03/29/2005 | US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/29/2005 | US6872721 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione |
| 03/29/2005 | US6872718 Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 03/29/2005 | CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/29/2005 | CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/29/2005 | CA2195745C Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 03/24/2005 | WO2005026344A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis |
| 03/24/2005 | WO2005026132A1 cAMP-SPECIFIC PHOSPHODIESTERASE INHIBITOR |
| 03/24/2005 | WO2005025503A2 A composition and method of treatment for urogenital conditions |
| 03/24/2005 | WO2004110379A3 A1 adenosine receptor antagonists |
| 03/24/2005 | WO2004096116A3 Diazabicyclononene derivatives |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050065148 Dipeptidyl peptidase inhibitors |
| 03/24/2005 | US20050065120 Compositions and methods for the treatment of urinary incontinence |
| 03/24/2005 | US20050065118 Compound containing 1,3,4-thiadiazole group; anticancer agents; autoimmune disease; antidiabetic agents |
| 03/24/2005 | US20050064586 Somatic cell derived embryonic stem cells and its differentiated cells |
| 03/24/2005 | US20050064539 Glycoprotein and process for producing the same |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050064045 Chemical ablation agent to cause tissue necrosis, and a biodegradable viscosity agent to form a highly viscous formulation for injection; prostatic ablation to treat benign prostatic hyperplasia |
| 03/24/2005 | US20050064039 Novel microsphere and method for production thereof |
| 03/24/2005 | US20050064037 Transdermal delivery of oxybutynin in gel formulations |
| 03/24/2005 | US20050063969 Assay |
| 03/24/2005 | US20050063943 Conjugated of hydroxyalkyl starch and an active agent |
| 03/24/2005 | DE10337638A1 Verfahren zur Behandlung der Prostatitis A method for the treatment of prostatitis |
| 03/24/2005 | DE10006836B4 Verwendung von Omega-3-Fettsäuren und/oder Verbindungen von Omega-3-Fettsäuren The use of omega-3 fatty acids and / or compounds of omega-3-fatty acids |
| 03/24/2005 | CA2542303A1 A composition and method of treatment for urogenital conditions |
| 03/23/2005 | EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor |
| 03/23/2005 | EP1516878A1 Refreshment capable of stimulating movement of digestive tract |
| 03/23/2005 | EP1516866A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
| 03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
| 03/23/2005 | EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 03/23/2005 | EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/23/2005 | EP1515968A2 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 03/23/2005 | EP1515961A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 03/23/2005 | EP1515959A1 Pharmaceutical salts of reboxetine |
| 03/23/2005 | EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 03/23/2005 | EP1515942A1 Carboxamides derivatives |
| 03/23/2005 | EP1515941A1 2-naphthamide derivatives |
| 03/23/2005 | EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 03/23/2005 | EP1515719A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 03/23/2005 | EP1515716A2 Indole derivatives having anti-angiogenetic activity |
| 03/23/2005 | EP1311285B1 Liquid pharmaceutical composition containing an erythropoietin derivative |
| 03/23/2005 | EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 03/23/2005 | CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists |
| 03/23/2005 | CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/23/2005 | CN1599620A Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 03/23/2005 | CN1599608A Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 03/23/2005 | CN1597677A Compounds and methods for modulation of estrogen receptors |
| 03/23/2005 | CN1597667A Quinazoline derivatives as angiogenesis inhibitors |
| 03/23/2005 | CN1597662A A kind of aromatic acid amide compound its preparation method and use |
| 03/23/2005 | CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 03/23/2005 | CN1596971A Kidney supplementing life prolonging preparation and its making method |
| 03/23/2005 | CN1596968A Kidney supplementing life prolonging effervescent tablet and its preparation method |
| 03/23/2005 | CN1596967A Kidney supplementing life prolonging granules and its preparation method |
| 03/23/2005 | CN1596951A Phellodendron bark disperse tablet and its preparation method |
| 03/23/2005 | CN1596920A Medicinal composition for treating cardiopathy and its preparation method and use |
| 03/23/2005 | CN1194014C Coupled cmpound of hematopoietin and polyethylene glycol |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CN1193749C Bladder irrigation original liguid |
| 03/22/2005 | US6869975 Linked biaryl compounds |
| 03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 03/22/2005 | US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/22/2005 | US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine) |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/22/2005 | US6869941 Combination of drospirenone and an estrogen sulphamate for HRT |
| 03/22/2005 | US6869605 Anticarcinogenic agents |
| 03/22/2005 | CA2257772C Bicyclic¬3.1.0|hexanes and related compounds |
| 03/17/2005 | WO2005023782A1 Substituted fused pyrimidine-4(3h)-one compound |
| 03/17/2005 | WO2005023238A1 Erg channel openers for the treatment of hyperexcitability-related neuronal diseases |